An Exploratory Investigation of Dietary Supplementation and the Effect on Common Symptoms of Perimenopause and Menopause

Semaine Health

Status: Completed

Conditions: Menopause Related Conditions; Menopause; Perimenopausal Disorder

Treatments: Dietary Supplement: Semaine Menopause Supplement

Study type: Interventional

Funder types: Industry

Identifiers

NCT05617287

20265

Details and patient eligibility

About

A combination of synergistic dietary supplements is hypothesized to significantly improve self-reported measures of menopausal symptoms when compared with a baseline without the intervention.

Enrollment: 42 patients

Sex: Female

Ages: 40 to 57 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Ability to take oral medication and be willing to adhere to the dietary supplement regimen (1 capsule per day)
• Moderate self-reported discomfort related to perimenopause or menopause. Participants will complete the menopause well-being survey and must answer an average of "moderate" or higher.

Exclusion criteria

• Current use of medication for high blood pressure or for blood thinning
• Currently undergoing chemotherapy or has previously been treated for cancer
• Pregnancy, breastfeeding, or attempting to become pregnant during the study
• Known allergic reactions to components of the dietary supplement (red clover extract, olive extract, bergamot extract )

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

42 participants in 1 patient group

Semaine Supplement

Experimental group

Description:

Participants are provided with a dietary supplement and are instructed to take 1 capsule per day. Participants are to take the supplement at the same time every day. If forgotten, they are to take it with the next meal. Participants will take a well-being assessment after each month (4 surveys total including the baseline.)

Treatment:

Dietary Supplement: Semaine Menopause Supplement